2-Part Multiple Ascending Dose Study for Safety and Pharmacokinetics in Healthy and Elderly Subjects
Completed · Phase 1 · Has a placebo group
Conditions studied: CNS
In brief
This is a single-center, randomized, double-blind, placebo-controlled, sequential, multiple-dose study. The study will be conducted in two parts: Part A (6 cohorts of healthy adults receiving evening dosing) and Part B (one cohort of elderly adults receiving evening dosing).
Key facts
- Study ID
- NCT01673451
- Run by
- Eisai Inc.
- People needed
- 24
- Starts
- 2012-08-01
- Expected to finish
- 2013-07-01
- Last updated by the study team
- 2013-10-11
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.
Where it is running
- Parexel, California Clinical Trials — Culver City, California, United States
- Study site — Glendale, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.